Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Learn what's the best investment strategy to help you maximize your returns and achieve your financial goals.
22,631 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
A bold move by Berkshire Hathaway’s new leadership shifted power in the tech landscape. This is how Greg Abel built b...
Want to grow your portfolio faster? This guide shows how to apply a stocks double right strategy with two momentum-fr...
As wage growth stalls for some workers, investors pursue dividend income. This piece examines how a $500,000 dividend...
Two giants in the U.S. cannabis space face off for investors: Green Thumb Industries and Curaleaf. This guide breaks ...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
A casual taste-test clip by McDonald’s CEO ignited a social-media firestorm. The incident quickly evolved into a broa...
Berkshire Hathaway buying back stock isn’t just a headline. It reflects how the company views its own value and how i...
Investors nudged Intel higher after AI infrastructure news signaled stronger demand for its CPU and accelerator lineu...
As Anthropic prepares for a public debut, many investors seek exposure to AI beyond private rounds. The AGIX ETF offe...
Interactive Brokers surged in the first half of 2026 as traders flocked to global markets. This guide breaks down the...